Employer with a benefit plan ยท SEC filer
NEOLEUKIN THERAPEUTICS, INC
Also filed as AQUINOX PHARMACEUTICALS, INC; AQUINOX PHARMACEUTICALS (USA) INC; Neurogene Inc.
188 E BLAINE ST, SEATTLE, WA 98102
EIN
98-0542593
SEC CIK
0001404644
SEC · 2026-08-14
Industry (SIC)
Pharmaceutical Preparations (2834)
SEC · 2026-08-14
Ticker
NGNE
SEC · 2026-08-14
Latest SEC filing
SCHEDULE 13G/A 2026-08-14
SEC · 2026-08-14
Benefit plan 1, 2023 filing
NEOLEUKIN THERAPEUTICS, INC RETIREMENT PLAN
DOL · 2024-11-26
Participants (start of year)
71
DOL · 2024-11-26
Plan features
code 3D2E2F2G2J2K2T
DOL · 2024-11-26
Plan type
Single-employer plan
DOL · 2024-11-26
Business code (NAICS)
541700
DOL · 2024-11-26
Benefit plan 1, 2023 filing
NEOLEUKIN THERAPEUTICS, INC RETIREMENT PLAN
DOL · 2024-09-23
Participants (start of year)
110
DOL · 2024-09-23
Plan features
code 2E2F2G2J2K2T3D
DOL · 2024-09-23
Plan type
Single-employer plan
DOL · 2024-09-23
Business code (NAICS)
541700
DOL · 2024-09-23